Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Zastosowanie systemu implantów bioindukcyjnych REGENETEN™ w przypadku łez o niepełnej grubości (IMPACT)

23 września 2026 zaktualizowane przez: Smith & Nephew, Inc.

Ocena bezpieczeństwa i skuteczności resorbowalnego implantu kolagenowego w leczeniu przedarć dużego stopnia o częściowej grubości; Prospektywne, wieloośrodkowe, randomizowane badanie kontrolne (badanie IMPACT)

The purpose of the study is to assess whether the REGENETEN™ Bioinductive Implant allows patients to get back to their everyday activities quicker than if the tendon is repaired by the standard repair technique 'Completion and Repair' for surgically treating partial-thickness rotator cuff tears.

Przegląd badań

Status

Rekrutacyjny

Warunki

Interwencja / Leczenie

Szczegółowy opis

The primary objective of this study is to evaluate the functional recovery of patients with high grade (>50%) partial thickness tears at 3 months when treated with either Isolated Bioinductive Repair (IBR) or Completion and Repair (CAR).

Typ studiów

Interwencyjne

Zapisy (Szacowany)

234

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Kontakt w sprawie studiów

Kopia zapasowa kontaktu do badania

Lokalizacje studiów

    • Victoria
      • Richmond, Victoria, Australia, 3121
        • Rekrutacyjny
        • OrthoSport Victoria
        • Główny śledczy:
          • Soong Chua
        • Kontakt:
          • Haydn Klemm
      • Madrid, Hiszpania, 28034
        • Rekrutacyjny
        • Hospital Ramón y Cajal
        • Kontakt:
          • Miguel Angel Ruiz Iban
        • Główny śledczy:
          • Miguel Angel Ruiz Iban
      • Madrid, Hiszpania, 28040
        • Rekrutacyjny
        • Hospital Fundación Jiménez Díaz
        • Kontakt:
          • Cristina Delgado del Cano
        • Główny śledczy:
          • Emilio Calvo
    • Alberta
      • Calgary, Alberta, Kanada, T2R 2G5
        • Rekrutacyjny
        • Access Orthopaedics
        • Kontakt:
          • Kristie More
        • Główny śledczy:
          • Ian Lo
    • Manitoba
      • Winnipeg, Manitoba, Kanada
        • Aktywny, nie rekrutujący
        • Pan Am Clinic
    • Ontario
      • Hamilton, Ontario, Kanada
        • Rekrutacyjny
        • Research St. Joseph's
        • Główny śledczy:
          • Moin Khan
        • Kontakt:
          • Danielle Dagher
    • Georgia
      • Rome, Georgia, Stany Zjednoczone, 30165
        • Rekrutacyjny
        • Harbin Clinic
        • Główny śledczy:
          • Brandon Bushnell
        • Kontakt:
          • Terri Brannon
    • Illinois
      • Rockford, Illinois, Stany Zjednoczone, 61107
        • Rekrutacyjny
        • OrthoIllinois LTD
        • Główny śledczy:
          • Scott Trenhaile
        • Kontakt:
          • Catherine Ayala
    • Maryland
      • Baltimore, Maryland, Stany Zjednoczone, 21215
        • Wycofane
        • Sinai Hospital Baltimore
    • Ohio
      • Garfield Heights, Ohio, Stany Zjednoczone, 44125
        • Wycofane
        • Cleveland Clinic - Sports Health
    • Pennsylvania
      • Pittsburgh, Pennsylvania, Stany Zjednoczone, 15213
        • Rekrutacyjny
        • University of Pittsburgh
        • Główny śledczy:
          • Albert Lin
        • Kontakt:
          • Alec Howard
    • Texas
      • Bedford, Texas, Stany Zjednoczone, 76021
        • Aktywny, nie rekrutujący
        • Texas Orthopedic Specialists
      • The Woodlands, Texas, Stany Zjednoczone, 77385
        • Wycofane
        • Houston Methodist The Woodlands
    • Wisconsin
      • Ashland, Wisconsin, Stany Zjednoczone, 54806
        • Wycofane
        • Memorial Medical Center
      • Milan, Włochy
        • Rekrutacyjny
        • IRCCS Istituto Ortopedico Galeazzi,
        • Kontakt:
          • Vincenzo Guarrella
        • Główny śledczy:
          • Ettore Taverna
      • Roma, Włochy
        • Rekrutacyjny
        • Fondazione Policlinico Universitario Campus Bio-Medico
        • Kontakt:
          • Giuseppe Longo
        • Główny śledczy:
          • Giuseppe Longo
      • Bath, Zjednoczone Królestwo
        • Rekrutacyjny
        • Sulis Hospital
        • Główny śledczy:
          • Andrew Chambler
      • Bristol, Zjednoczone Królestwo
        • Rekrutacyjny
        • North Bristol NHS Trust
        • Kontakt:
          • Steven Barnfield
        • Główny śledczy:
          • Iain Packham
      • Salford, Zjednoczone Królestwo, M6 8HD
        • Wycofane
        • Northern Care Alliance NHS Foundation Trust
    • Surrey
      • Chertsey, Surrey, Zjednoczone Królestwo, KT16 0PZ
        • Rekrutacyjny
        • Ashford & St Peter's Hospitals NHS Foundation Trust
        • Główny śledczy:
          • Ali Narvani
        • Kontakt:
          • Timnit Tekie

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

18 lat i starsze (Dorosły, Starszy dorosły)

Akceptuje zdrowych ochotników

Nie

Płeć kwalifikująca się do nauki

Wszystko

Opis

Inclusion Criteria:

  • The subject must provide written informed consent.
  • Subject is > eighteen (18) years of age (no upper limit).
  • Subject has an isolated high-grade (>50% or >6mm) (Ellman grade III) partial thickness tear of supraspinatus or supraspinatus with infraspinatus.
  • Subject has failed a minimum of 3 months of conservative management for treatment of partial thickness rotator cuff tear.
  • Subject willing and able to make all required study visits.
  • Subject able to follow instructions and deemed capable of completing all study questionnaires.

Exclusion Criteria:

  • Subjects with insufficient tendon tissue quality for management and protection of the tendon injury using the isolated REGENETEN Bioinductive Implant system.
  • Subjects where the prescribed Physical Therapy guidelines stated in the protocol are not suitable for their rehabilitation.
  • Subjects with Samilson-Prieto osteoarthritis grade 2 and greater.
  • Subjects with current or prior infection of the ipsilateral shoulder.
  • Subjects with known hypersensitivity to bovine-derived materials.
  • Subjects with known inflammatory arthropathy, history of inflammatory arthropathy, chronic joint disease or chronic pain of upper extremities (shoulder(s), arm(s)).
  • Subjects with prior shoulder surgery on index shoulder, including subacromial decompression, biceps tenodesis/tenotomy, and acromioclavicular joint (ACJ) excision/distal clavicle excision (DCE).
  • Subjects with a planned surgery on the contra-lateral shoulder within the study period.
  • Systemic steroid use (oral, IV) or local steroid injection within 3 months of the date of surgery.
  • Subjects with a full thickness rotator cuff tear.
  • Subjects with a subscapularis tear requiring repair.
  • Subjects requiring a concomitant labral fixation procedure, concomitant surgery for bone defects requiring bone implantation or for superior labral tear from anterior to posterior (SLAP).
  • Subjects requiring a concomitant os acromiale fixation procedure.
  • Subjects with glenohumeral joint instability (multiple dislocations/subluxations).
  • Subjects with condition(s) that contraindicate or complicate outcomes of Isolated Bioinductive Repair or completion and repair e.g., > Hamada 3 rotator cuff arthropathy on X-ray, Goutallier atrophy > Grade 3, proximal humeral fracture or scapular fracture, avascular necrosis of the humeral head.
  • Subjects with neurologic conditions effecting either upper extremity.
  • Subjects who are unable to tolerate magnetic resonance imaging (MRI), due to psychiatric or medical contraindications.
  • Subjects who are pregnant or breast feeding.
  • Subjects who are currently involved in any injury litigation relating to the index shoulder.
  • Subjects with current workers compensation claim.
  • Subjects who are enrolled, or plan to enroll, in another clinical trial during this study that would affect the outcomes of this study.
  • Subjects with a history of poor compliance with medical treatment, physical therapy (PT)/rehabilitation, or clinical study participation.
  • Subject who, in the opinion of the Investigator, has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, mental retardation, and drug or alcohol abuse.
  • Subjects who do not meet the indication or are contraindicated according to specific Smith+Nephew REGENETEN System's Instructions for Use (IFUs).
  • Any subject that meets the definition of a Vulnerable Subject per ISO 14155 Section 3.55.
  • Subjects who have participated previously in this clinical trial and who have healed or been withdrawn
  • Subjects with a medical or physical condition that, in the opinion of the Investigator, would preclude safe subject participation in the study.

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Leczenie
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Pojedynczy

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: Isolated Bioinductive Repair

Surgical treatment of partial-thickness rotator cuff tears with the REGENETEN Bioinductive Implant system.

Isolated Bioinductive repair with REGENETEN™ Bioinductive Implant

Inne nazwy:
  • Implant bioindukcyjny REGENETEN™
Aktywny komparator: Completion and Repair

Surgical treatment of partial-thickness rotator cuff tears using the standard surgical technique 'Completion and Repair'.

Standard surgical repair using the 'Completion and Repair' technique.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Change in Western Ontario Rotator Cuff (WORC)
Ramy czasowe: Change from baseline to 3 months post-intervention

The WORC Index is self-administered, and includes a 5 different domains (physical symptoms, sports and recreation, work, social function, and emotions). Each question uses a visual analog scale (VAS) representing a 100-point scale ranging from 0 to 100. The maximum score is 2100 (worst possible symptoms). Zero (0) represents no symptoms at all. The final score can also be presented as a percentage by subtracting the total from 2100, dividing by 2100, and multiplying by 100. This will give you an overall percentage. The total final WORC Index scores can, therefore, range from 0% (lowest functional status level) to 100% (highest functional status level).

Change from baseline to 3 months post-intervention

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Western Ontario Rotator Cuff (WORC)
Ramy czasowe: Pre-op, 6 weeks, 3, 6, 12 and 24 months

The WORC Index is self-administered, and includes a 5 different domains (physical symptoms, sports and recreation, work, social function, and emotions). Each question uses a visual analog scale (VAS) representing a 100-point scale ranging from 0 to 100. The maximum score is 2100 (worst possible symptoms). Zero (0) represents no symptoms at all. The final score can also be presented as a percentage by subtracting the total from 2100, dividing by 2100, and multiplying by 100. This will give you an overall percentage. The total final WORC Index scores can, therefore, range from 0% (lowest functional status level) to 100% (highest functional status level).

Pre-op, 6 weeks, 3, 6, 12 and 24 months
Constant-Murley Score
Ramy czasowe: Pre-Op, 3, 6, 12 and 24 months

The Constant-Murley Score is a validated assessment of pain and shoulder functionality. The Constant Score is divided into 4 subscales: pain (15 points; VAS score range of 0-15), activities of daily living (20 points; range 0=worst, 5=best), strength (25 points; 1 point given per 0.5 kg of weights raised), and range of motion - forward flexion, external rotation, abduction and internal rotation of the shoulder (40 points; range 0=worst, 10=best). The higher the score, the higher the quality of function.

Pre-Op, 3, 6, 12 and 24 months
Subjective Shoulder Value (SSV) score
Ramy czasowe: Pre-Op, 6 weeks, 3, 12 and 24 months

The SSV is defined as a patient's subjective shoulder assessment expressed as a percentage of an entirely normal shoulder, which would score 100% (0% to 100% scale with 100% being normal).

Pre-Op, 6 weeks, 3, 12 and 24 months
EuroQol 5 Dimension 5 Level (EQ-5D-5L) VAS & index scores
Ramy czasowe: Pre-Op, 3 and 6 weeks, 3, 6, 12 and 24 months

To assess the subject's health state. The EQ-5D-5L is composed of the EQ- 5D-5L descriptive system and the EQ Visual Analogue scale (EQ VAS).

The descriptive system comprises 5 dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/depression). Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. Responses are coded as single-digit numbers expressing the severity level selected in each dimension. For instance, 'slight problems' (e.g. 'I have slight problems in walking about') is always coded as '2'. The digits for the five dimensions are combined in a 5-digit code. The EQ- 5D-5L index value is derived by using the vendor supplied calculator to convert each 5-digit EQ- 5D-5L profile.

The EQ VAS corresponds to a 20 cm vertical, visual analogue scale ranging from 'the best health you can imagine' to 'the worst health you can imagine'.

A higher number is a better outcome.

Pre-Op, 3 and 6 weeks, 3, 6, 12 and 24 months
Change in Western Ontario Rotator Cuff (WORC)
Ramy czasowe: Change from Pre-op to 6 weeks, 3, 6, 12 and 24 months

The WORC Index is self-administered, and includes a 5 different domains (physical symptoms, sports and recreation, work, social function, and emotions). Each question uses a visual analog scale (VAS) representing a 100-point scale ranging from 0 to 100. The maximum score is 2100 (worst possible symptoms). Zero (0) represents no symptoms at all. The final score can also be presented as a percentage by subtracting the total from 2100, dividing by 2100, and multiplying by 100. This will give you an overall percentage. The total final WORC Index scores can, therefore, range from 0% (lowest functional status level) to 100% (highest functional status level).

Change from Pre-op to 6 weeks, 3, 6, 12 and 24 months
Change in Constant-Murley Score
Ramy czasowe: Change from Pre-Op to 6 weeks, 3, 12 and 24 months

The Constant-Murley Score is a validated assessment of pain and shoulder functionality. The Constant Score is divided into 4 subscales: pain (15 points; VAS score range of 0-15), activities of daily living (20 points; range 0=worst, 5=best), strength (25 points; 1 point given per 0.5 kg of weights raised), and range of motion - forward flexion, external rotation, abduction and internal rotation of the shoulder (40 points; range 0=worst, 10=best). The higher the score, the higher the quality of function.

Change from Pre-Op to 6 weeks, 3, 12 and 24 months
Change in Subjective Shoulder Value (SSV) score
Ramy czasowe: Change from Pre-Op to 6 weeks, 3, 12 and 24 months

The SSV is defined as a patient's subjective shoulder assessment expressed as a percentage of an entirely normal shoulder, which would score 100% (0% to 100% scale with 100% being normal).

Change from Pre-Op to 6 weeks, 3, 12 and 24 months
Percent Achieving Minimal Clinically Important Difference (MCID) for Constant-Murley Score
Ramy czasowe: Pre-Op, 3, 6, 12 and 24 months

The Constant-Murley Score is a validated assessment of pain and shoulder functionality. The Constant Score is divided into 4 subscales: pain (15 points; VAS score range of 0-15), activities of daily living (20 points; range 0=worst, 5=best), strength (25 points; 1 point given per 0.5 kg of weights raised), and range of motion - forward flexion, external rotation, abduction and internal rotation of the shoulder (40 points; range 0=worst, 10=best). The higher the score, the higher the quality of function.

Pre-Op, 3, 6, 12 and 24 months
Percent Achieving MCID for Western Ontario Rotator Cuff (WORC)
Ramy czasowe: Pre-op, 6 weeks, 3, 6, 12 and 24 months

The WORC Index is self-administered, and includes a 5 different domains (physical symptoms, sports and recreation, work, social function, and emotions). Each question uses a visual analog scale (VAS) representing a 100-point scale ranging from 0 to 100. The maximum score is 2100 (worst possible symptoms). Zero (0) represents no symptoms at all. The final score can also be presented as a percentage by subtracting the total from 2100, dividing by 2100, and multiplying by 100. This will give you an overall percentage. The total final WORC Index scores can, therefore, range from 0% (lowest functional status level) to 100% (highest functional status level).

Pre-op, 6 weeks, 3, 6, 12 and 24 months
Percent Achieving MCID for Subjective Shoulder Value (SSV) score
Ramy czasowe: Pre-Op, 6 weeks, 3, 12 and 24 months

The SSV is defined as a patient's subjective shoulder assessment expressed as a percentage of an entirely normal shoulder, which would score 100% (0% to 100% scale with 100% being normal).

Pre-Op, 6 weeks, 3, 12 and 24 months
Patient Satisfaction
Ramy czasowe: 6 weeks, 3, 6, 12 and 24 months

Comprise of 2 questions:

  1. Overall, I am satisfied with the outcome of my surgery
  2. I would recommend the procedure to a friend.

Question rated by the patient with Strongly Agree, Agree, Neither Agree nor Disagree, Disagree, Strongly Disagree.

6 weeks, 3, 6, 12 and 24 months
Pain, Visual analog scale (VAS) Score
Ramy czasowe: Pre-Op, 3 and 6 weeks, 3, 12 and 24 months

Pain is assessed on a 100-point scale ranging from 0 to 100, with zero (0) representing no pain and 100 representing the worst pain imaginable.

Pre-Op, 3 and 6 weeks, 3, 12 and 24 months
MRI Tendon Findings in subjects with Isolated Bioinductive Repair versus completion via Sugaya Score
Ramy czasowe: 12 months

The Sugaya score is classified into 5 categories: Type I to Type V. Type I indicates sufficient thickness with homogenously low intensity. Type II indicates sufficient thickness with partial high intensity. Type III indicates insufficient thickness without discontinuity. Type IV indicates presence of a minor discontinuity, suggesting a small full-thickness tear. Type V indicates the presence of a major discontinuity, suggesting a medium or large full-thickness tear.

12 months
MRI Tendon Findings in subjects with Isolated Bioinductive Repair versus completion via MRI assessment of percent filling
Ramy czasowe: 12 months

Percent tissue infil is graded at site of original tear and classified as 0% to < 25%, 25% to < 50%, 50% to < 75%, 75% to < 100% and 100%.

12 months
MRI Tendon Findings in subjects with Isolated Bioinductive Repair versus completion via MRI assessment of the signal intensity pattern
Ramy czasowe: 12 months

The Signal Intensity Pattern will be graded into 3 categories. Type I: Heterogeneous high signal intensity with fluid-like bright foci, Type II: Heterogeneous high signal intensity without fluid-like bright foci, Type III: Heterogeneous or homogeneous low signal intensity.

12 months
MRI Tendon Findings in subjects with Isolated Bioinductive Repair versus completion via Rotator cuff tendon thickness
Ramy czasowe: 12 months

Tendon thickness will be measured in millimeters (mm).

12 months
MRI Tendon Findings in subjects with Isolated Bioinductive Repair versus completion via Goutallier classification
Ramy czasowe: 12 months

The Goutallier classification will be used to classify the fatty infiltration of the rotator cuff. The Goutallier classification ranges from a grade of 0 indicating a completely normal muscles without any fatty streaks to a grade of 4 which indicates that more fat than muscle is present.

12 months
Incidence of Revision Surgery
Ramy czasowe: 1, 3 and 6 weeks, 3, 6, 12 and 24 months

Number of subjects requiring revision surgery

1, 3 and 6 weeks, 3, 6, 12 and 24 months
Time to return to work
Ramy czasowe: Up to 24 months

Number of weeks taken to return to work following surgery

Up to 24 months
Time to return to driving
Ramy czasowe: Up to 24 months

Number of weeks taken to return to driving following surgery

Up to 24 months
Time to return to sports
Ramy czasowe: Up to 24 months

Number of weeks taken to return to sport following surgery

Up to 24 months
Total operative time
Ramy czasowe: Inter-operative time

Time expressed in minutes

Inter-operative time
Physical Therapy Utilization
Ramy czasowe: Up to 24 months

Number visits following index surgery

Up to 24 months
Cumulative days of opioid use
Ramy czasowe: Day 1-14

Self-reported opioid use diary completed by the patient on a daily basis, from day 0-14, documenting opioid use. Consumption daily (YES/NO) x14 days, 'Have you taken any opioid medication today for shoulder pain?'

Day 1-14
Duration of shoulder immobilization following index surgery
Ramy czasowe: 1, 3 and 6 weeks, 3 months

Number of days

1, 3 and 6 weeks, 3 months

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Sponsor

Śledczy

  • Krzesło do nauki: Laura Mills, Smith & Nephew, Inc.

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

30 sierpnia 2022

Zakończenie podstawowe (Szacowany)

15 kwietnia 2027

Ukończenie studiów (Szacowany)

28 lutego 2029

Daty rejestracji na studia

Pierwszy przesłany

29 czerwca 2022

Pierwszy przesłany, który spełnia kryteria kontroli jakości

29 czerwca 2022

Pierwszy wysłany (Rzeczywisty)

6 lipca 2022

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

28 września 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

23 września 2026

Ostatnia weryfikacja

1 września 2026

Więcej informacji

Terminy związane z tym badaniem

Inne numery identyfikacyjne badania

  • REGENETEN.2021.04

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

NIE

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Tak

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .